Sitagliptin Use in Patients With Diabetes and Heart Failure

Sitagliptin use was not associated with an increased risk of all-cause hospitalizations or death, but was associated with an increased risk of HF-related hospitalizations among patients with T2D with pre-existing HF (JACC)